HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes.

AbstractOBJECTIVE:
To review [(123)I]FP-CIT (Ioflupane I 123, DaTscan) SPECT imaging and its role in clinical practice.
BACKGROUND:
[(123)I]FP-CIT is a radiopharmaceutical that binds reversibly to striatal presynaptic dopamine transporters.
METHODS:
We review the two principal multicenter clinical trials of [(123)I]FP-CIT SPECT imaging and provide additional, previously unreported information. Study 1 was a trial of [(123)I]FP-CIT SPECT in patients with early suspected parkinsonism that compared baseline scans to the consensus clinical diagnosis established 3 years later. Study 2 was a trial of [(123)I]FP-CIT SPECT in patients with established diagnoses of parkinsonian syndrome (PS) or essential tremor (ET).
RESULTS:
In Study 1, positive percent agreement (abnormal baseline scan and clinical diagnosis of PS at 36 months [n = 71]) was 78-79%. Negative percent agreement (normal baseline scan and a clinical diagnosis of non-PS at 36 months [n = 28]) was 97%. In study 2, positive percent agreement (abnormal scan and a clinical diagnosis of PS [n = 158]) was 92-97%. Negative percent agreement (normal scan and a clinical diagnosis of ET [n = 27]) was 74-96%.
CONCLUSION:
[(123)I]FP-CIT SPECT brain imaging is used to assist in the evaluation of adult patients with suspected PS and may help differentiate ET from PS as an adjunct to other diagnostic evaluations.
AuthorsRobert A Hauser, Donald G Grosset
JournalJournal of neuroimaging : official journal of the American Society of Neuroimaging (J Neuroimaging) Vol. 22 Issue 3 Pg. 225-30 (Jul 2012) ISSN: 1552-6569 [Electronic] United States
PMID21410815 (Publication Type: Journal Article, Review)
Copyright© 2011 by the American Society of Neuroimaging.
Chemical References
  • Radiopharmaceuticals
  • Tropanes
  • 2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropane
Topics
  • Adult
  • Brain (diagnostic imaging)
  • Evidence-Based Medicine
  • Female
  • Humans
  • Male
  • Parkinsonian Disorders (diagnostic imaging)
  • Radiopharmaceuticals
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Tomography, Emission-Computed, Single-Photon (methods)
  • Tropanes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: